In the coming years, genomics will impact clinical practice in multiple ways. However, one of the most important applications will be in the determination of the best treatments in personalized medicine. This is, in fact, one of the fields in which genetic variants have already been most successful and useful to clinicians. Here, we briefly review the current state of the art on pharmacogenomics and its applications to modern cardiovascular medicine.
Pharmacogenetics in Cardiovascular Disorders: An Update on the Principal Drugs / I.M. Predazzi, R. Mango, G.D. Norata, N. Di Daniele, D. Sergi, F. Romeo, G. Novelli. - In: AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS. - ISSN 1175-3277. - 13:2(2013 Mar 29), pp. 79-85. [Epub ahead of print] [10.1007/s40256-013-0020-9]
Pharmacogenetics in Cardiovascular Disorders: An Update on the Principal Drugs
G.D. Norata;
2013
Abstract
In the coming years, genomics will impact clinical practice in multiple ways. However, one of the most important applications will be in the determination of the best treatments in personalized medicine. This is, in fact, one of the fields in which genetic variants have already been most successful and useful to clinicians. Here, we briefly review the current state of the art on pharmacogenomics and its applications to modern cardiovascular medicine.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
